EMEA approves psoriasis treatment
NICE aims to reduce delays in patient access
AZ hopes for another 'megabrand'
Concerns linger over side-effects
Company concentrates on four areas
In-depth inquiry launched
Consortium to advise pharmacists
Small-scale study is positive
Abbott hopes for global brands